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Indomethacin (IN) is a widely used nonsteroidal anti-inflammatory drug. In this study, four
photoproducts of IN (IN1eIN4) were produced and isolated from photoirradiated IN. This
study investigated the abilities of IN and its photoproducts to scavenge hydroxyl radicals
and inhibit xanthine oxidase (XO). The hydroxyl radical-scavenging activity was measured
in vitro by electron spin resonance spectrometry using 5,5-dimethyl-1-pyrroline-N-oxide as
a spin trapping agent. Enzyme activity was measured by continuous monitoring of uric
acid formation, using xanthine as a substrate. The results showed that, among all the
related products, IN has the strongest hydroxyl radical-scavenging (IC50 ¼ 65 mM) and XO
inhibitory (IC50¼ 86 mM) effects. To further understand the stereochemistry of the reactions
between these IN derivatives and XO, we performed computer-aided molecular modeling.
IN was the most potent inhibitor with the most favorable interaction in the reactive site.
Various photoproducts exhibited affinity toward XO as a result of the absence of hydrogen
bonding with molybdopterin domain.
Copyright ª 2013, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license.1. Introduction pathological processes [1,2]. Xanthine oxidase (XO), anReactive oxygen species (ROS), including superoxide anion
O

2 , hydroxyl radical (HO), and hydrogen peroxide (H2O2), can
initiate inflammation, which contributes to a number ofemistry, College of Medi
. Lin).
work.
ministration, Taiwan. Publessential enzyme that catalyzes the oxidation of hypoxan-
thine to xanthine and then to uric acid, is a critical biological
source of ROS [3]. An antioxidant with dual roles of ROS-
scavenging and XO inhibition activities can be beneficial as acine, Taipei Medical University, Taipei, Taiwan, ROC.
ished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
NH
3
CO
C
O
Cl
2
3
3a
7a
4
5
6
7
9
1'
2' 3'
4'
5'6'
O
O
HO
CH
3
18a
N
H
3
CO
R
C
O
Cl
CH
3
2
33a
7a
49
5
8
6
7
1'
2' 3'
4'
5'6'
IN R= CH2COOH 
IN2 R=CH3
IN3 R= CH2COOCH3
IN4 R= CH2COOC2H5
 IN1 
Fig. 1 e Structures of IN and its photoproducts (IN1eIN4).
IN [ indomethacin.
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as gout. Indomethacin (IN) has widely been used as a
nonsteroidal anti-inflammatory drug (NSAID) because of its
cyclooxygenase (COX) inhibitory activity [4]. Treatment with
NSAIDs is often accompanied by adverse effects such as
gastrointestinal damage and platelet dysfunction [5]. Recent
reports have noted the ability of NSAIDs to eliminate and
inhibit free radicals [6]. For example, nimesulide and its
metabolite 4-hydroxynimesulie have been found to protect
cartilage against oxidative stress through their ROS-
scavenging activity. IN has demonstrated ROS-scavenging
activity [7] but has not been proved effective in XO inhibition.
Photoproducts of NSAIDs may have unexpected effects on
biological systems [8,9]. In our previous studies, photoprod-
ucts of IN, including g-lactone (IN1), decarboxylated product
(IN2), methyl ester (IN3), and ethyl ester (IN4), were produced
through photoirradiated synthesis [10]. IN3 inhibited prosta-
glandin (PGE)2 and nitric oxide (NO) production, and
expressed inducible NO synthase (iNOS) and COX-2 in
lypopolysaccharide (LPS)-stimulated macrophage more
effectively than IN [11]. However, light energy absorbed by IN
may convert to heat, and photolysismay be accompanied by a
thermal reaction when the activation energy is reached.
Amber or light-resistant containers are commonly used to
prevent a photochemical reaction. This study evaluated the
HO-scavenging and XO inhibition activities of IN and its
photoproducts. Structure-based molecular modeling was also
performed to further understand the stereochemistry of these
IN derivatives and XO.2. Methods
2.1. Chemicals and reagents
IN, 5,5-dimethyl-1-pyrroline-N-oxide (DMPO), ferrous sulfate
(FeSO4,7H2O), XO (EC 1.2.3.2.), and xanthine were obtained
from Sigma Chemical Company (St Louis, MO, USA). Hydrogen
peroxide (H2O2) was purchased from Acros Chemical Com-
pany (Morris Plains, NJ, USA) and EDTA from Merck (Darm-
stadt, Germany). Methanol and ethanol used in the studywere
of HPLC grade (JT Baker, Phillipsburg, NJ, USA).
2.2. Photodegradation of IN
An amount of 200 mg of IN was weighed and placed in a 100-
mL volumetric flask. Methanol was added to make a concen-
tration of 5.6 mM (2.0 mg/mL). The solution was transferred to
a 100-mL quartz sample vial. A Philips 400 W UV lamp was
used as a light source (HPA 400/30S UV lamp, Philips, Brux-
elles, Belgium). The samplewas irradiated for 14 dayswith the
UV lamp mounted horizontally overhead, 30 cm from the
sample. IN1eIN3 were isolated from the irradiated sample in
methanol and IN4 from the irradiated sample in ethanol [8].
Chemical structures of IN and its photoproducts are shown in
Fig. 1 {IN, 1-(4-chloro-benzoyl)-5-methoxy-2-methyl-indol-3-
acetic acid; IN1, 8-(4-chloro-benzoyl)-3a-hydroxy-5-methoxy-
8a-methyl-2-oxo-2,3,3a,8a-tetrahydro-1H-furo-[2,3-b]-indole;
IN2, 1-(4-chloro-benzyl)-5-methoxy-2,3-dimethyl-indol; IN3,
[1-(4-chloro-benzoyl)-5-methoxy-2-methyl-indol-3-yl]-aceticacid methyl ester; and IN4, [1-(4-chloro-benzoyl)-5-methoxy-
2-methyl-indol-3-yl]-acetic acid ethyl ester} [11].
2.3. HO-scavenging activity
HO.-scavenging activity was measured using the electron
spin resonance (ESR) spin-trapping method. The reaction
mixture contained 20 mL of 500 mM DMPO, 20 mL of 0.5 mM
FeSO4, 20 mL of 1 mM EDTA, and 20 mL of the sample solution.
After rapid stirring, the reaction mixture was placed into a
capillary ESR tube. Recording of the ESR spectrum was
started 40 seconds after the addition of 20 mL of 1 mM H2O2.
Deionized water was used instead of the sample solution for
control experiments. Intensities of the DMPOeOH spin
signal (secondary peak) in electron paramagnetic resonance
(EPR) spectrometry were used to evaluate the scavenging
activity of the isolated compounds. HO-scavenging activity
was calculated according to the following formula:
Scavenging activityð%Þ ¼ 1 Isample=Icontrol
 100 (1)
where Icontrol and Isample represent the intensity of the signal in
the absence and presence of the sample, respectively.
2.4. ESR spectrometry
The DMPOeOH spin adduct was detected by ESR spectroscopy
at room temperature using a Bruker EMX-6/1 ESR spectrom-
eter equipped with Bruker WIN-EPR Sim-Fonia program
(Billerica, MA). ESR measurement conditions were as follows:
magnetic field, 347.5  5.0 mT; microwave power, 2.0 mW;
modulation frequency, 100 kHz; modulation amplitude, 5 G;
and time constant, 0.6 seconds [12].
2.5. XO activity assay
Enzyme activity was determined spectrophotometrically by
measuring uric acid formation continuously at 295 nm, using
xanthine as a substrate. The XO assay consisted of a reaction
mixture containing 20 mM 3-(cyclohexylamino)-1-
propanesulfonic acid, 38 mM EDTA, 3 u/L XO, and 50 mM
xanthine. The assay was started by adding the enzyme to the
reaction mixture, with or without inhibitors. The assay
mixture was incubated for 3 minutes at 37 C, and absorbance
was noted every 5 seconds. Data obtained for the enzyme
assays were plotted using Microsoft Office Excel 2010 [13].
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The X-ray crystal structure of bovine XO was retrieved from
the RCSB Protein Data Bank (http://www.rcsb.org/pdb, PDB
code 3NVY), and the C-chain of this protein was used for
docking studies of IN and its photoproducts. Small molecules
were removed from the C-chain, hydrogen atoms were added,
and the resultant protein structure was used in the docking
simulation. Three-dimensional structures of compounds
were built and optimized by energy minimization using the
MM2 force field and a minimum RMS gradient of 0.05 in the
software Chem3D 6.0 (CambridgeSoft Corp., Cambridge, MA,
USA). Docking simulation was performed using the GOLD 5.0
program on an HP xw6600 workstation with Intel Xeon E5450/
3.0 GHz Quadcores as the processors. The GOLD program
utilizes a genetic algorithm (GA) to perform flexible ligand
docking simulations. In the present study, for each of the 30
independent GA runs, a maximum number of 100,000 GA
operations were performed on a single population of 100 in-
dividuals. Operator weights for crossover, mutation, and
migration were set to be 95, 95, and 10, respectively. The
GoldScore fitness functionwas applied for scoring the docking
poses of compounds. The docking region was defined to
encompass the active site of XO. The best docking solution
(with the highest GOLD fitness score) for a compound was
chosen to represent the predicted binding mode to the active
site of XO [14].0.0
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Fig. 2 e (A) Scavenging activity of IN and its photoproducts
against HO. Equal amounts of IN and the photoproducts
IN1eIN4 (100 mM) were used in the Fenton reaction for ESR
spectrometry. (B) ESR spectra of DMPOeOH adduct
obtained from the Fenton reaction with IN and IN1 at
various concentrations (0e200 mM). (C) Inhibitory activities
of IN and its photoproducts against the Fenton reaction
generated hydroxyl radicals. DMPO [ 5,5-dimethyl-1-
pyrroline-N-oxide; ESR [ electron spin resonance;
IN [ indomethacin.3. Results
Among the oxygen radicals, HO is most reactive and damages
adjacent biomolecules severely. We investigated the HO-
scavenging abilities of the four photoproducts (IN1eIN4) using
ESR spectrometry. HO, which was generated by the Fenton
reaction, exhibited a four-line ESR spectrum (DMPO-OH ad-
ducts). Fig. 2A shows the HO suppression activity of the iso-
lated photoproducts IN1eIN4 at a concentration of 100 mM. IN1
showed comparable activity to IN, whereas IN2eIN4 did not
exhibit substantial suppressive activity in this assay. Forma-
tion of the DMPOeOH spin adduct was inhibited significantly
by 150 mM IN and completely by 250 mM IN. IN and its photo-
products demonstrated HO-scavenging activity in a dose-
dependent manner (Fig. 2B). The results are shown in terms
of the inhibition scavenging activity (%). IC50 values were
determined from the regression line obtained using the least-
squares method, as shown in Table 1. IN had a stronger HO-
scavenging effect, with IC50 ¼ 65 mM, than its photoproducts.
IC50 values of IN1, IN3, and IN4 were 84, 110, and 120 mM,
respectively. IN2 did not display a significant inhibitory ac-
tivity against HO (IC50 > 500 mM; Fig. 2C).
Table 1 shows the IC50 values for XO inhibition by IN and its
photoproducts. IN had the most potent inhibitory effect on
XO, with IC50 ¼ 86 mM. IC50 values of IN2 and IN3 were 93.3 mM
and 88.8 mM, respectively; however, IN1 and IN4 did not
exhibit a significant inhibitory effect (IC50 > 100 mM). All the
photoproducts exhibited a weaker inhibitory effect than IN.
To provide a further insight into the inhibitory effects of IN
on XO and to explain the structureeactivity relationships, amolecular model was created for IN docking on XO (Fig. 3). We
focused on IN dockings in themolybdopterin domain of XO. In
the co-crystal structure of salicylateeXO [15], both carboxyl-
ated atoms of salicylate were close to the guanidinium group
of Arg880, to the hydroxyl side chain of Thr1010, and to
Glu1261 via water. The aromatic inhibitor was aligned parallel
to the ring of Phe914, whereas the phenyl group of Phe 1009
was aligned perpendicular to the ring of the inhibitor or
Table 1 e Hydroxyl radical-scavenging and XO inhibition
activities of IN and its photoproducts.
Compounds Scavenging
activity (IC50, mM)
XO inhibition
activity (IC50, mM)
IN 65 86
IN1 84 >100
IN2 500 93.3
IN3 110 88.8
IN4 120 >100
IN ¼ indomethacin; XO ¼ xanthine oxidase.
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the active site of XO was performed using the docking pro-
gram GOLD 5.0 and the crystal structure of bovine XO (PDB
code 3NVY). IN docking in the molybdopterin domain of XO
displayed a similar position and interaction to salicylate
binding. The p-chlorobenzoyl of IN had a stacking force with
Phe 914, and an indole ring stretched to the space surrounded
by several residues including Phe1009, Val1011, Leu648,
Leu873, and Leu1014. The carboxylate group of IN can interact
with Arg880 by forming a salt bridge that is a combination of
electrostatic interactions and hydrogen bonding (Fig. 3A). The
binding energy of IN was also proved to be more potent in XO
docking than other photoproducts (Fig. 3B), which is consis-
tent with the results of enzyme activity. The photoproducts
might have shown less affinity for XO than IN because of the
absence of salt bridge between IN and the molybdopterin
domain.4. Discussion
NSAIDs are the principal therapeutic agents used to treat in-
flammatory disorders and inhibit COX, which catalyzes the
formation of prostaglandin precursors from arachidonic acidFig. 3 e (A) Molecular model of indomethacin binding to the
active site of xanthine oxidase. Protein structure is
represented as a ribbon. IN (yellow) and some interacting
amino acid residues (cyan) are shown as sticks. Hydrogen
atoms are omitted for clarity. The red broken lines indicate
salt bridge interactions. (B) GOLD fitness scores of IN and its
photoproducts were obtained using the GOLD 5.0 program.
IN [ indomethacin.[16]. ROS has been demonstrated to be a mediator of inflam-
mation [17]. Thus, drugs with inflammatory activity
commonly display ROS-eradicating activity, typically by
downregulating the production of tumor necrosis factor-a and
iNOS or by scavenging ROS directly. Ikeda et al [6] demon-
strated the superoxide-scavenging activity of IN, and Costa
et al [7] reported the scavenging activity of H2O2. The results of
our study revealed that IN demonstrates HO-scavenging ac-
tivity (Fig. 2, Table 1). Other reactive species, including peroxyl
radical (ROO), HO, O

2 , H2O2, and HOCl, as well as reactive
nitrogen species, nitric oxide (NO), and peroxynitrite anion
(ONOOe), also play vital roles in the inflammatory process and
pathophysiologies [18]. IN counteracts oxidative stress, which
accounts for its enhanced efficacy in anti-inflammation.
XO produces uric acid and ROS during purine catabolism
[3]. An excess of uric acid can lead to gout, which is respon-
sible for oxidative damage to living tissues. Currently, NSAIDs
are the preferred treatment for acute gout attacks, given their
effects on the suppression of inflammation coupled with their
analgesic properties. Among these drugs, IN is considered to
be most potent [19e21]. The main objectives of acute gout
therapy are rapid and safe resolution of pain and restoration
of functional ability. In the treatment of chronic gout, XO in-
hibitors, such as allopurinol, are most effective in reducing
serum urate in patients who are overproducers or under-
excretors of uric acid [22e24]. Experimental data indicated
that IN exhibited an inhibitory effect on XO (Table 1).
Furthermore, computer-aided molecular modeling provided
an insight into this observation. This finding implies that
NSAIDs may have polyfunctional curative effects in gout
treatment, including those of anti-inflammation, anti-
oxidation, and XO inhibition. The photoproducts exhibited
less potent activity than the parental IN. This suggests that IN
should not be exposed to light during storage to avoid its
photodegradation, because its photoproducts exhibit reduced
efficacy.
In conclusion, this study was performed to clarify the
beneficial effects of IN and its photoproducts in inflammatory
diseases where ROS and XO are pathogenically involved. Our
results indicate that the anti-inflammatory and analgesic
agent IN is an HO scavenger. IN also binds to the active site of
XO to block its catalytic activity and results in reduced ROS
production. Therefore, IN partially accounts for the reduced
anti-inflammatory effects of various photoproducts.
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